Overweight and obesity

Obesity is defined as an excessive accumulation of body fat beyond normal levels that is associated with health risks.¹
  • The body mass index (BMI) is ≥ 30 kg/m² of body surface area.

  • Pre‑obesity is defined as a BMI of 25.0–29.9 kg/m².

  • Overweight is defined as a BMI of ≥ 25.0 kg/m².

Obesity is defined as an excessive accumulation of body fat beyond normal levels that is associated with health risks.¹

  • The body mass index (BMI) is ≥ 30 kg/m² of body surface area.

  • Pre‑obesity is defined as a BMI of 25.0–29.9 kg/m².

  • Overweight is defined as a BMI of ≥ 25.0 kg/m².

OVERWEIGHT AND OBESITY

Obesity is defined as an excessive accumulation of body fat beyond normal levels that is associated with health risks.¹
  • The body mass index (BMI) is ≥ 30 kg/m² of body surface area.
     
  • Pre‑obesity is defined as a BMI of 25.0–29.9 kg/m².
     
  • Overweight is defined as a BMI of ≥ 25.0 kg/m².
Overall, in Germany:2

19%

of all men and women are affected by obesity.

27.6%

of women

are overweight
(without obesity).

41.3%

of men

are overweight (without obesity).

1

The number of people who are overweight or obese has increased in recent years. The main reasons are thought to be changes in dietary behaviour and a widespread lack of physical activity.1

Overall, in Germany:2

19%

of all men and women are affected by obesity.

27.6%

of women

are overweight (without obesity).

41.3%

of men

are overweight
(without obesity).

1

The number of people who are overweight or obese has increased in recent years. The main reasons are thought to be changes in dietary behaviour and a widespread lack of physical activity.¹

Possible causes of obesity

The following factors may contribute to overweight (in alphabetical order):1

Folgende Ursachen können zu Adipositas führen (alphabetische Reihenfolge)1

  • Depressive disorders; eating disorders 
    (e.g. binge‑eating disorder [BED], night‑eating disorder)

  • Endocrine disorders  
    (e.g. hypothyroidism, Cushing’s syndrome)

  • Excessive energy intake
    due to constant availability and a wide range of energy‑dense and highly processed foods and beverages

  • Familial predisposition, genetic causes
     
  • Lack of physical activity 
    predominantly sedentary occupations

  • Medications
    (e.g. antidepressants, antipsychotics, antiepileptics, certain antidiabetic drugs, glucocorticoids, some contraceptives, beta‑blockers)

  • Other causes
    (e.g. excessive weight gain during pregnancy, smoking cessation)

     

Therapy FOR overweight and obesity

If the following criteria are met, an indication for therapy in cases of overweight or obesity is present:¹

BMI ≥ 30 kg/m² or

Overweight with a BMI between 25 and < 30 kg/m² and the simultaneous presence of overweight‑related health disorders (e.g. hypertension, type 2 diabetes mellitus), or

  • Predominantly abdominal fat distribution (waist circumference ≥ 102 cm in men or ≥ 88 cm in women), or

  • Diseases that are exacerbated by overweight, or

  • A high level of psychosocial distress

The goal of weight reduction is the long‑term reduction of body weight, associated with a decrease in weight‑related risks and comorbidities, prevention of work disability and premature retirement, and an improvement in quality of life.¹

Basic therapy

Basic therapy

The foundation of all weight management is a basic therapy consisting of dietary modification, increased physical activity and behavioural change. The design of this basic therapy depends, among other factors, on the severity of overweight or obesity.¹ formoline L112 EXTRA provides support during basic therapy.3

The foundation of all weight management is a basic therapy consisting of dietary modification, increased physical activity and behavioural change. The design of this basic therapy depends, among other factors, on the severity of overweight or obesity.¹ formoline L112 EXTRA provides support during basic therapy.3

Nutrition therapy
Nutrition therapy

Nutrition therapy focuses on reducing overall energy intake. For long‑term weight reduction, a sustained lower‑energy diet is required. A daily energy deficit of about 500–600 kcal, or an individually determined deficit, is recommended. Highly restrictive or one‑sided diets should be avoided.

Hilfe bei der Umsetzung von Verhaltensänderungen und der Einnahme von formoline L112 EXTRA bietet die My-formoline Begleit-App.

Physical activity therapy
Physical activity therapy

Physical activity therapy encourages people with overweight or obesity to increase their daily and leisure‑time physical activity. Goals should be realistic and easy to understand.

Hilfe bei der Umsetzung von Verhaltensänderungen und der Einnahme von formoline L112 EXTRA bietet die My-formoline Begleit-App.

Behavioural changes
Behavioural changes

Behavioural changes recommended for people with overweight and obesity include self‑monitoring of behaviours and weight‑loss progress, stimulus control, setting realistic goals, reinforcement strategies (such as rewarding positive changes), relapse prevention, strategies for dealing with weight regain and social support.

Hilfe bei der Umsetzung von Verhaltensänderungen und der Einnahme von formoline L112 EXTRA bietet die My-formoline Begleit-App.

Nutrition therapy
Nutrition therapy

Nutrition therapy focuses on reducing overall energy intake. For long‑term weight reduction, a sustained lower‑energy diet is required. A daily energy deficit of about 500–600 kcal, or an individually determined deficit, is recommended. Highly restrictive or one‑sided diets should be avoided.

Hilfe bei der Umsetzung von Verhaltensänderungen und der Einnahme von formoline L112 EXTRA bietet die My-formoline Begleit-App.

Physical activity therapy
Physical activity therapy

Physical activity therapy encourages people with overweight or obesity to increase their daily and leisure‑time physical activity. Goals should be realistic and easy to understand.

Hilfe bei der Umsetzung von Verhaltensänderungen und der Einnahme von formoline L112 EXTRA bietet die My-formoline Begleit-App.

Behavioural changes
Behavioural changes

Behavioural changes recommended for people with overweight and obesity include self‑monitoring of behaviours and weight‑loss progress, stimulus control, setting realistic goals, reinforcement strategies (such as rewarding positive changes), relapse prevention, strategies for dealing with weight regain and social support.

Hilfe bei der Umsetzung von Verhaltensänderungen und der Einnahme von formoline L112 EXTRA bietet die My-formoline Begleit-App.

Pharmacological therapy

If significant and sustained weight reduction cannot be achieved or maintained with basic therapy alone, pharmacological treatment of obesity may be considered. In Germany, approved options currently include, among others, GLP‑1 agonists and a lipase inhibitor.1

Prerequisites for pharmacological therapy for weight reduction or for maintaining achieved weight loss are:1
  • BMI ≥ 30 kg/m2

  • BMI ≥ 27 kg/m²
(when using a lipase inhibitor: BMI ≥ 28 kg/m²) and the presence of obesity‑associated risk factors and/or comorbidities, or

Pharmacological therapy should always be carried out in combination with a multimodal basic therapy.1

Are you considering starting treatment with a weight‑loss injection, or are you planning to end such a therapy and maintain your weight afterward?

Talk to your doctor about

formoline L112 EXTRA.

Are you considering starting treatment with a weight‑loss injection, or are you planning to end such a therapy and maintain your weight afterward?

Contact

How to reach us

"Thinking beyond GLP-1" is an initiative of Certmedica International GmbH. www.certmedica.com

Phone

If you have any questions, please contact our medical‑scientific department at

+49 6021 150930

Email

email@certmedica.de

Fax

+49 6021 15093-329

Address

Certmedica International GmbH

Magnolienweg 17

63741 Aschaffenburg
Germany